Niti Aayog's roadmap to turn India into $691 billion bioeconomy
NITI Aayog proposes six BioMissions including GeneIndia, AgriBio 2.0, BioX Foundry, One Health Grid, Marine Biotechnology, and BioPharmaNext.
The roadmap targets a $691 billion bioeconomy by 2035 through mission-driven national initiatives.
A Rs 50,000-crore BioEconomy Growth Fund is recommended for 2026-2035 to bridge lab-to-market gaps.
The plan aims to strengthen capabilities in healthcare, agriculture, industrial biotechnology, and disease surveillance.
Institutional mechanisms include an Empowered Committee on National BioMissions, a National BioData Council, and a fast-track IP approval system.
Story angle
Center-right
Mostly straight facts, with a light government- or market-friendly tilt.
About how the story is framed, not whether the facts are true.
Times of India
Center-right
Mixed factuality
Who owns this?
Times Group
Bennett, Coleman & Co. (Sahu Jain family)
India's largest newspaper group by circulation.
Wikipedia: Sahu Jain family